Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca…

Astrazeneca (AZN) reached $71.46 at the closing of the latest trading day, reflecting a +2.26% change compared to its last…

Trading in AstraZenecas (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to…

Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile…

Pharma giant’s chief discusses shifting listing to US in potential blow to UK capital…

AstraZeneca reports total voting rights at over 1.55 billion shares…

AstraZeneca chief executive Pascal Soriot is considering moving the companys stock market listing to the United States, The Times reported…

Sir Pascal Soriot is frustrated with restrictions on medicines by Nice and pricing under an NHS rebate scheme…

…

For investors in the United States, its pretty easy to get overexposed to domestic stocks. These are the brands that…

Attraktive Investmentperspektive: AstraZeneca zeigt Interesse an KI-Onkologie-Konsortium "PROmAI"^EQS-Media / 28.06.2025 / 14:56 CET/CESTOnco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco…

Whats the biggest misconception about investing? The idea that you need a lot of money to get started is certainly…

Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium^Emittent / Herausgeber: MCS Market…

Vancouver, Kanada - 27. Juni 2025 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" oder…

IRW-PRESS: Onco-Innovations Limited: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-KonsortiumVancouver, Kanada…